NEW YORK (GenomeWeb News) – More than 98 percent of Life Technologies' voting shareholders have approved the company's pending $13.6 billion acquisition by Thermo Fisher Scientific, Life Tech announced after the close of the market on Wednesday.

The voting took place at a special shareholders' meeting on Wednesday, and the 98 percent of votes cast in favor of the deal represents more than 72 percent of all outstanding shares, Life Tech said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.